Method for producing zirconium dioxide nanoparticles in the presence of amino acids

Hydrothermal treatment of zirconium IV compounds with specific amino acids addresses the challenge of producing stable, high-concentration zirconium dioxide nanoparticle dispersions, enhancing transmittance and crystallinity for industrial applications.

JP7584417B2Active Publication Date: 2024-11-15MATHYM
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
JP2021531375
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-11-30
Filing Date
2019-11-28
Publication Date
2024-11-15
Estimated Expiration
2039-11-28

AI Technical Summary

Technical Problem

Current methods for preparing zirconium dioxide nanoparticles face challenges in achieving stable dispersions with high concentrations, good transmittance, and crystallinity while maintaining mild synthesis conditions, which are difficult to scale up industrially.

Method used

A method involving hydrothermal treatment of zirconium IV compounds in the presence of amino acids, specifically those with a ratio of acid functionality to amine functionality greater than or equal to 1, at pH below 7, allows for the production of zirconium dioxide nanoparticles with high concentrations and improved dispersion stability.

Benefits of technology

The method achieves zirconium dioxide nanoparticle dispersions with transmittance of 20% or more at 400 nm and 95% or more at 800 nm, viscosity below 10 mPa.s, and low organic matter content, facilitating handling and dosage control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007584417000011
    Figure 0007584417000011
  • Figure 0007584417000012
    Figure 0007584417000012
  • Figure 0007584417000001
    Figure 0007584417000001
Patent Text Reader

Abstract

The present invention relates to a method for producing nanoparticles of zirconium dioxide (ZrO2) by hydrothermal treatment of a zirconium IV compound in the presence of water, at a pH of less than 7, and in the presence of at least one amino acid containing at least 4 carbon atoms, where the ratio of acid functional groups to amine functional groups is greater than or equal to 1. The present invention also relates to zirconium dioxide nanoparticles that exhibit a transmittance in the visible spectrum of greater than or equal to 20% at 400 nm and greater than or equal to 95% at 800 nm, measured at a concentration of 40% by weight in water.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a method for the preparation of zirconium dioxide nanoparticles by hydrothermal treatment carried out in the presence of an amino acid. The invention also relates to the use of these nanoparticles, especially in the form of a dispersion. [Background technology]

[0002] Currently, there is strong interest in zirconium dioxide (zirconia) nanoparticles in various industrial fields. Zirconium dioxide ZrO 2 One of the techniques for preparing nanoparticles of ZrO consists in hydrothermal treatment of zirconium compounds, especially zirconium salts with an oxidation degree of zirconium of 4. Thus, the preparation of ZrO nanoparticles by hydrothermal treatment 2 During the preparation of the particles, the zirconium is neither oxidized nor reduced, and its degree of oxidation does not change.

[0003] Zirconium dioxide is in the form of crystals and has three different crystal structures: monoclinic, tetragonal, and cubic, depending on the temperature, the presence of dopants, and the size of the crystals. For nanometer-sized particles, the tetragonal and cubic phases are difficult to distinguish by X-ray diffractometry (XRD), and in the prior art and in the present description, they are both classified under the name "tetragonal / cubic". The monoclinic phase is easily distinguished from the other two. By adjusting the preparation method, it is possible to favor one of these crystal structures.

[0004] However, the preparation of stable dispersions of zirconium dioxide nanoparticles that exhibit improved properties in terms of crystallinity, colloidal stability, narrow polydispersity, and transparency remains a real challenge. In fact, most of the methods available so far provide weak control over the size of the particles with colloidal stability, which can be significantly improved. In particular, these dispersions generally exhibit high levels of aggregation, which negatively impacts the properties of the desired end product. Zirconium dioxide nanoparticles can be used especially in the preparation of nanocomposite and ceramic materials.

[0005] In the case of ceramic materials and ceramic composites, the use of colloidal dispersions of zirconium dioxide as an additive, as a main component, or as a second component can make it possible to obtain improved optical, thermal and mechanical properties due to better control of the microstructure and porosity. The use of colloidal dispersions makes it possible to reduce the temperature of the heat treatment compared to methods that do not require such dispersions, which generally makes it possible to obtain finer microstructures or crystals that are better distributed in the composites.

[0006] Among the applications of these ceramics, we can mention the production of dense or nanoporous coatings, high-transmittance nanoceramics based on zirconia, the production of nanocomposites based on zirconia / alumina, their use as sintering additives, and the preparation of ceramic inks for 2D and 3D printing.

[0007] For nanocomposites, dispersions of zirconium dioxide nanoparticles are generally mixed with monomeric, oligomeric, polymeric, or prepolymeric resins. Nanocomposite materials containing a high percentage of zirconia nanoparticles exhibit improved refractive index, abrasion resistance, elastic modulus, and radiopacity, as well as reduced shrinkage, compared to the matrix. At the same time, if the nanoparticles are not aggregated in the matrix and have a sufficiently small size, the nanocomposite material can maintain a high transmittance in visible light. The total transmittance (T) of a material corresponds to the ratio of the luminous flux transmitted through a certain thickness of said material to the incident luminous flux, and can be expressed as a value between 0 and 1 or a corresponding percentage (T%).

[0008] Among the applications of these composites, mention may be made of the dental sector (composites, varnishes, adhesives), optics, electronics and energy (high refractive index, anti-reflective and anti-scratch coatings), lighting (high refractive index coatings for extracting light from devices, e.g. OLED and HB-LED) and cosmetics.

[0009] Additionally, in connection with these applications, it is preferred that the dispersions have high visible transmittance so as not to significantly alter the aesthetic appearance of the composite material resulting from the nanoparticle dispersion.

[0010] Although stable dispersions have been available so far, they are generally not very concentrated in nanoparticles, mainly due to the technical problems associated with their preparation. In fact, at high concentrations, zirconium dioxide nanoparticles tend to aggregate, while the dispersion gels. In addition, the transmittance of dispersions of zirconium dioxide nanoparticles generally decreases as the concentration of zirconium dioxide nanoparticles increases.

[0011] EP 2,371,768 B1 describes an aqueous dispersion of zirconium oxide which, at a concentration of 30% by weight, exhibits a transmittance of up to 44.3% at 400 nm and up to 98.2% at 800 nm, and a viscosity of less than 20 mPa.s at 25° C.

[0012] The document U.S. Patent Application Publication No. 2005 / 123465 describes ZrO 2 A method for preparing dispersions of particles and their modification with caproic acid is described. 2 It consists of obtaining a colloidal dispersion of colloids and mixing it with a solution containing aminocaproic acid, which is not synthesized by hydrothermal treatment in the presence of an amino acid.

[0013] Document FR 2,899,906 describes the preparation of metal oxide nanoparticles from zirconium tetraisopropoxide in the presence of acetylacetone, propanol and paratoluenesulfonic acid. 2 Once the particles are obtained, they may be mixed with aminocaproic acid, which is not a hydrothermal treatment in the presence of an amino acid.

[0014] Lin et al. (Materials Chemistry and Physics, 206 (2018), pp. 136-143) describe a hybrid compound based on zirconia and silicone for encapsulating LEDs. Films obtained from this hybrid compound show a transmittance of more than 95% at wavelengths between 400 and 800 nanometers.

[0015] (Materials Chemistry and Physics, 152 (2015), pp. 135-146) reported the synthesis of ZrO by mixing a zirconium IV compound and an arsenic type III dopant and / or L-cysteine ​​in alcohol at basic pH and room temperature. 2 describes the synthesis of particles based on a hydrothermal treatment at acidic pH.

[0016] In any case, obtaining a concentrated dispersion in zirconium dioxide nanoparticles makes it possible to easily handle these nanoparticles, as long as the user does not have to handle a powder product. Indeed, even if obtaining a powder proves to be advantageous in terms of packaging and transportation, a concentrated dispersion will make it easier to handle the nanoparticles, provided that it is stable.

[0017] On the one hand, the stability of the dispersion allows the control of the dosage of uniformly dispersed nanoparticles.Finally, obtaining transparent dispersions of nanoparticles is particularly advantageous in certain fields, for example in the dental field. [Prior art documents] [Patent documents]

[0018] [Patent Document 1] European Patent No. 2,371,768B1 [Patent Document 2] US Patent Application Publication No. 2005 / 123465 [Patent Document 3] French Patent No. 2,899,906 [Non-patent literature]

[0019] [Non-Patent Document 1] Lin et al., Materials Chemistry and Physics, 206 (2018), pp. 136-143 [Non-Patent Document 2] Perreira et al., Materials Chemistry and Physics, 152 (2015), pp. 135-146 [Non-Patent Document 3] J. Humlicek, "Data Analysis for Nanomaterials: Effective Medium Approximation, Its Limits and Implementations," Ellipsometry at the Nanoscale, 2013, pp. 145-178. Summary of the Invention [Problem to be solved by the invention]

[0020] Similarly, the methods described in the literature for preparing this type of material involve experimental conditions (pressure, temperature, or hydrothermal treatment time) that make them difficult to implement on an industrial scale. Taking all these limitations into account, it is possible to obtain a significant amount of ZrO2 with good colloidal dispersion, good transmittance, and good crystallinity while maintaining relatively mild synthesis conditions. 2 The development of technological methods capable of producing nanoparticles remains a subject of ongoing exploration and would in itself represent a very important step forward in the industrialization of high-quality nanodispersions of zirconia, a material of particular interest in many technical fields. [Means for solving the problem]

[0021] Applicants have found quite unexpectedly that by preparing zirconium dioxide nanoparticles by hydrothermal treatment in the presence of an amino acid, it is possible to moderate the synthesis conditions and increase the concentration and dispersion quality of the zirconium dioxide nanoparticles.

[0022] More specifically, the present invention provides a method for producing zirconium dioxide (ZrO) by hydrothermal treatment of a zirconium IV compound in the presence of water, at a pH of less than 7, and in the presence of at least one amino acid containing at least 4 carbon atoms, the ratio of acid functional groups to amine functional groups being equal to or greater than 1. 2 The present invention relates to a method for preparing nanoparticles of the present invention.

[0023] The present invention also relates to zirconium dioxide nanoparticles having a visible transmittance at 400 nm or greater, and at 800 nm or greater, of 20% or greater, measured at a concentration of 40% by weight in water.

[0024] The present invention also relates to zirconium dioxide (ZrO 2 The present invention also relates to a dispersion of said nanoparticles of the formula: ZrO. These nanoparticles can be stabilized by conventional stabilizers or by at least one amino acid containing at least 4 carbon atoms with an acid / amine functional ratio of ≥ 1. More precisely, ZrO 2 The nanoparticle dispersions contain up to 80% by weight of ZrO 2 It may contain nanoparticles and may have a transmittance in a 40% by weight dispersion, advantageously ranging from 20% up to 83% at a wavelength of 400 nm, advantageously ranging from 95% up to 99.9% at a wavelength of 800 nm.

[0025] The dispersion also has a very low viscosity in water at 40% by weight, preferably ≧1 mPa.s and ≦10 mPa.s. Furthermore, the dispersion maintains a high transmittance at higher concentrations. The 65% by weight dispersion has a transmittance at 400 nm ranging from 15%, preferably from 45%, up to 75%, and at 800 nm ranging from 85%, preferably from 95%, up to 99%. Furthermore, the dispersion has a high refractive index, preferably ≧1.40 at 40% by weight and ≧1.50 at 65% by weight.

[0026] Furthermore, the dispersion after purification with water has a very low level of organic material, preferably 15% by weight or less, more preferably 8% by weight or less, even more preferably 5% by weight or less, and even more preferably 3.5% by weight or less.

[0027] The dispersion also has a very low dispersion index, preferably from 1 to 7, more preferably from 1 to 4, even more preferably from 1 to 2, and even more preferably from 1 to 1.5.

[0028] The present invention also relates to nanoparticles in powder form having an amino acid stabilizer. In particular, the powder is obtained by drying the dispersion described above. Hereinafter, the term "particles" will also be used to refer to ZrO 2 It can be used to represent nanoparticles.

[0029] The invention and the advantages obtained therefrom will become apparent from the following figures and examples given to illustrate the invention without limiting it. [Brief description of the drawings]

[0030] [Figure 1] FIG. 1 shows a TEM image of the zirconium dioxide nanoparticles of Example 16. [Diagram 2] FIG. 1 shows photographs of various samples of dispersions according to the invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0031] Zirconium IV Compounds As indicated above, the process according to the invention makes it possible to obtain zirconium dioxide nanoparticles by hydrothermal treatment of a zirconium IV compound. Advantageously, the zirconium IV compound used in the process according to the invention is selected from the group consisting of zirconium halides. Preferably, the zirconium IV compound is zirconium oxychloride (ZrOCl 2 ).

[0032] In a preferred embodiment, the zirconium IV compound is zirconium oxychloride octahydrate (ZrOCl 2 8H 2 This embodiment is advantageous because the water molecules provided by the hydrated form of the zirconium IV compound may be sufficient, so that no water needs to be added to perform the hydrothermal treatment.

[0033] In certain embodiments, the water of the hydrothermal treatment is derived exclusively from the hydrated form of the zirconium IV compound.

[0034] It should be noted that the zirconium IV compound used in the process according to the invention is not zirconium dioxide.

[0035] amino acid According to the invention, an amino acid contains at least 4 carbon atoms, advantageously 4 to 12 carbon atoms, more advantageously 4 to 6 carbon atoms. The amine functions of the amino acids may be primary, secondary, or tertiary. However, primary amine functions are preferred. The possible carbon atoms of the secondary and tertiary amine functions are counted in the number of carbon atoms of the amino acid.

[0036] The acid functional group of an amino acid is a carboxylic acid functional group C(=O)OH, the carbon atom of which is counted in the number of carbon atoms of the amino acid.

[0037] The amino acids may be straight or branched chain, but are preferably straight chain.

[0038] The amino acids not only affect the hydrothermal treatment conditions (temperature, pressure), but also the polydispersity and the visible range transmittance of the dispersion of zirconium dioxide nanoparticles.

[0039] According to the invention, the hydrothermal treatment is carried out in the presence of an amino acid having an acid / amine functional ratio greater than or equal to 1. This ratio is preferably approximately 1.

[0040] In fact, the Applicant has noticed that it is not possible to obtain a stable dispersion of zirconium dioxide nanoparticles if the amino acid has more amine functions than acid functions, and therefore amino acids such as lysine do not make it possible to obtain a dispersion of zirconium dioxide nanoparticles that is stable under the conditions of the invention. In certain embodiments, an amino acid may contain some acid functional groups and some amine functional groups.

[0041] In another particular embodiment, the amino acid may contain several acid functional groups and one amine functional group.

[0042] In a preferred embodiment, the amino acid contains one acid functional group and one amine functional group.

[0043] In another particular embodiment, several amino acids may be used in this manner.

[0044] Thus, the amino acids are preferably selected, alone or in mixtures, from the group consisting of aminobutanoic acid, aminopentanoic acid, aminohexanoic acid, aminoheptanoic acid, aminooctanoic acid, aminononanoic acid, aminodecanoic acid, aminoundecanoic acid and aminodecanoic acid, more preferably from the group consisting of aminobutanoic acid, aminopentanoic acid and aminohexanoic acid, even more preferably from the group consisting of 4-aminobutanoic acid, also known as 4-aminobutyric acid, 2-aminopentanoic acid, also known as norvaline, 5-aminopentanoic acid, also known as 5-aminovaleric acid and 6-aminohexanoic acid, also known as 6-aminocaproic acid, alone or in mixtures.

[0045] In a particular embodiment, the amino acids are produced in situ from amino acid precursors by hydrolysis. The term "amino acid precursor" is understood to mean a molecule that does not have both an amine function and an acid function and that can be converted into an amino acid in the presence of water under the conditions of the hydrothermal treatment according to the invention. In other words, in this particular embodiment, no amino acid is introduced into the reaction medium. Only compounds that, when hydrolyzed, produce the amino acid are introduced.

[0046] A preferred family of amino acid precursors is that of the lactams. Advantageously, the amino acid precursor is therefore selected from the group consisting of pyrrolidone and N-methylpyrrolidone (NMP).

[0047] In another particular embodiment, the method is carried out in the presence of an amino acid and an amino acid precursor. Thus, in this embodiment, the method is carried out with two sources of amino acids. The amino acid obtained from the precursor may be the same as the amino acid introduced in situ, or it may be a different amino acid.

[0048] It should be noted that the use of an acid alone, an amine alone, or a mixture of the two does not provide the same advantages as the use of an amino acid or mixture of amino acids.

[0049] It should be noted that functionalization of zirconia nanoparticles obtained by methods other than those of the present invention with amino acids does not provide the same advantages as the use of amino acids or mixtures of amino acids during hydrothermal treatment. In other words, preparation of zirconia particles in the absence of amino acids and then functionalization of these particles with amino acids results in the formation of ZrO nanoparticles according to the present invention. 2 It is not possible to obtain particles with nanoparticle properties.

[0050] Hydrothermal treatment operating conditions According to the invention, zirconium dioxide nanoparticles are produced by subjecting a zirconium IV compound to a hydrothermal treatment, which can be carried out under an inert atmosphere (e.g. under argon or nitrogen) or in air, preferably in air.

[0051] Advantageously, the hydrothermal treatment is carried out at a temperature of at least 100°C, preferably at least 150°C, more advantageously between 170 and 220°C, even more advantageously between 180 and 200°C.

[0052] The skilled person knows how to select the duration of the hydrothermal treatment, in particular as a function of the temperature and pressure selected. In general, the longer the duration of the hydrothermal treatment, the lower the process temperature required to ensure good production of nanoparticles in crystalline form. By way of example, the duration may be less than 48 hours, or even less than 24 hours. According to a preferred embodiment, the duration may be between 60 and 180 minutes.

[0053] However, depending on the experimental conditions, an increase in temperature may be sufficient to ensure hydrothermal treatment, in particular if the hydrothermal treatment is carried out at a temperature of at least 180° C., for example with a sufficiently slow increase, preferably of a few degrees per minute, more preferably of the order of 10° C. per minute.

[0054] It is thus possible to carry out the process according to the invention continuously or batchwise ("batch" process).

[0055] The skilled person will know how to adapt the experimental conditions, in particular the temperature and duration of the hydrothermal treatment as well as the increase in temperature, depending on the chosen method of carrying out the process and the desired yield for the production of nanoparticles.

[0056] Preferably, the hydrothermal treatment is carried out at a pressure of 0.1 MPa or more. Advantageously, the hydrothermal treatment is carried out at a pressure of 2 MPa or less, more preferably 0.1 to 2 MPa, even more preferably 0.12 to 1.5 MPa, even more preferably 0.15 to 0.6 MPa. Thus, the hydrothermal treatment can be carried out at a pressure of 0.1 MPa to 0.6 MPa.

[0057] The use of amino acids therefore allows to operate under favourable conditions compared to prior art processes, which allows to use cheaper equipment, for example autoclave sized equipment to obtain a maximum pressure of 0.6 MPa.

[0058] Generally, the pressure of the hydrothermal treatment results from the temperature and the compounds used in the reaction. Optionally, the pressure may be advantageously increased by an inert gas, such as nitrogen or argon.

[0059] The treatment is carried out at a pH below 7, more preferably at a pH between 1 and 6, and even more preferably at a pH between 3 and 5. However, in addition to the amino acid, the process is preferably carried out without the introduction of a Bronsted acid. Without wishing to be bound by any theory, it is believed that the reaction of the zirconium IV compound with water results in the formation of H + The production of ions can lead to acidification of the reaction medium. Advantageously, no Bronsted acid base is introduced before carrying out the hydrothermal treatment.

[0060] If the hydrothermal treatment is carried out in the presence of additional water, the amino acid concentration is advantageously between 1 and 13 mol.l -1 , more preferably 1.5 to 4 mol.l -1 Also in the presence of additional water, the zirconium IV concentration is advantageously between 0.1 and 8 mol.l. -1 , more preferably 0.5 to 2 mol.l -1 It is.

[0061] As already indicated, the method according to the invention may be carried out with the zirconium IV compound used in hydrated form, in which case there is no need to add water. In other words, even if it is possible to supply water, the number of water molecules of the zirconium IV compound in hydrated form is sufficient to carry out the hydrothermal treatment and to result in zirconium dioxide nanoparticles. Thus, in a particular embodiment, the water is obtained exclusively from the hydrated form of the zirconium IV compound. This embodiment is also applicable when amino acid precursors are used.

[0062] This particular embodiment is particularly advantageous because, in addition to the fact that the amount of water used may be significantly reduced, the applicant has realized that the pressure can be significantly reduced: in fact, in this particular embodiment, it is possible to carry out the hydrothermal treatment at a pressure of 0.1 MPa or more and 0.6 MPa or less, more advantageously 0.4 MPa or less.

[0063] Hydrothermal treatment without the addition of water typically results in a viscous paste, which surprisingly can be easily dispersed in water to give a stable dispersion of zirconium dioxide nanoparticles.

[0064] Preferably, the amino acid is present in a molar ratio of at least 1 relative to the zirconium IV compound, more preferably from 1 to 50, even more preferably from 2 to 50, even more preferably from 3 to 30.

[0065] When the molar ratio of amino acid to zirconium compound is less than 1, the amount of amino acid added is not sufficient to interact with the entire surface of the synthesized nanoparticles. This deficiency leads to the formation of anisotropic monoclinic ZrO, similar to that obtained by hydrothermal treatment of zirconium precursors in aqueous media in the absence of a stabilizer. 2 This leads to the formation of polydisperse aggregates of nanoparticles.

[0066] Advantageously, the zirconium dioxide nanoparticles are doped with transition metals, such as yttrium and / or lanthanides, such as gadolinium and / or cerium, more particularly oxides of these metals, preferably Y 2 O 3 , CEO 2 , or Gd 2 O 3 To do this, the hydrothermal treatment may be carried out in the presence of one or more dopant sources, preferably a yttrium source, and / or a cerium source, and / or a gadolinium source. Preferably, the yttrium source is YCl 3 Preferably, the cerium source is CeCl 3 Preferably, the gadolinium source is GdCl 3 It is. In general, the dopant source may be hydrated or non-hydrated.

[0067] In general, the doping element source is introduced in an amount of at most 20 mol %, preferably at most 12 mol %, and preferably at least 0.1 mol %, more preferably at least 1 mol %, relative to the zirconium IV. The doping element source may therefore in particular be between 0.1 and 20 mol %.

[0068] Generally, the source of the doping element is introduced into the reaction medium prior to the hydrothermal treatment.

[0069] Doping allows certain properties to be improved. In the case of yttrium, cerium and gadolinium, for example, it allows in particular to modify the size, morphology and crystalline phase of the particles. In general, controlled doping of these elements leads to particles exhibiting smaller sizes, higher tetragonal phase contents and more spherical morphologies. Furthermore, when producing dense ceramic materials from these nanoparticles, the presence of the doping elements also allows the tetragonal phase to be stabilized in a metastable state at room temperature, depending on the doping rate, making it possible to obtain solid ceramic materials free of cracks and with remarkable mechanical properties of toughness and resistance to fracture. By increasing the amount of dopant to obtain materials with high ionic conductivity or high permeability, the cubic phase can also be stabilized in some or all of the material. During the sintering heat treatment, the presence of the doping elements makes it possible to limit the growth of the crystal grains to obtain finer microstructures, often accompanied by increased hardness and improved mechanical properties.

[0070] The method according to the present invention is 2 It may also include a step of purifying the nanoparticles, which may be carried out, for example, by washing and / or rinsing with water, and in particular, this step makes it possible to remove amino acid molecules that do not interact with the nanoparticles as functionalizing and / or stabilizing agents.

[0071] ZrO 2 The nanoparticles may be isolated, for example by drying to obtain a powder, which may then be dispersed in a fluid, for example water, alcohol, especially glycerol or propylene glycol.

[0072] ZrO 2 Nanoparticles As already mentioned, the present invention also relates to dispersions in water of zirconium dioxide nanoparticles in the range of up to 80% by weight, stabilized with an amino acid and exhibiting a transmittance in a 40% by weight dispersion advantageously ranging from 20% to a maximum of 83% at a wavelength of 400 nm, advantageously ranging from 95% to a maximum of 99.9% at a wavelength of 800 nm. The present invention also relates to nanoparticles in powder form, advantageously stabilized with an amino acid, advantageously obtained by hydrothermal treatment.

[0073] Transmittance refers to the total transmittance, ie the sum of the direct transmittance (corresponding to "in-line transmittance") and the indirect transmittance (corresponding to "diffuse transmittance").

[0074] The total transmittance of the dispersion is typically measured at room temperature in water at 20° C., for example with a double beam spectrophotometer, such as the V-670 model from JASCO. A quartz cuvette with an optical path length of 10 mm is used. ZrO 2 The nanoparticles are dispersed in water at the desired concentration. The transmittance values ​​measured for the dispersion, expressed as a percentage of the transmittance measured for a cell filled with deionized water, are an increasing function of the incident wavelength in the range of 200 nm to 1000 nm, including the visible region (380 to 780 nm). For example, the value measured at 600 nm is greater than that measured at 400 nm, which is smaller than that measured at 800 nm. The total transmittance value at a fixed wavelength generally increases as the concentration of nanoparticles decreases. On the other hand, the total transmittance of ZrO 2 It is not proportional to the concentration of nanoparticles and there is no correlation between the transmittance at different wavelengths, in other words it is not possible to predict the transmittance at a given concentration or at a given wavelength from a single measurement at different concentrations or at different wavelengths.

[0075] The proportion of organic matter (TMO) present in the aqueous dispersion is calculated as a percentage of the mass of the nanoparticles. This measurement is carried out on the nanoparticles after drying at 120 ° C using a Kern DBS type desiccator. The dried particles are introduced into a crucible and then the loss of mass as a function of temperature is recorded by thermogravimetric analysis (TGA) at a speed of 10 ° C / min between 30 and 900 ° C using, for example, a thermal analyzer of the TGA4000 type from Perkin Elmer. The percentage of organic matter corresponds to the ratio of the loss of mass between 160 and 600 ° C to the initial mass of the dried particles.

[0076] This percentage will vary depending on the embodiment used. Preferably, the level of organic matter is no more than 15% by weight, more preferably no more than 8% by weight, even more preferably no more than 5% by weight, and even more preferably no more than 3.5% by weight.

[0077] The refractive index of the dispersion is typically measured at a wavelength of 589 nm in water at 20° C. using a refractometer such as the Abbemat 200 model from Anton Paar. 2 The particles are dispersed in water at a desired concentration. The refractive index values ​​measured for the dispersion generally increase as the particle concentration increases.

[0078] In general, the dispersions according to the invention advantageously have a high refractive index of ≧1.40 and ≦1.90 at a concentration of 40% by weight, and ≧1.50 and ≦2.00 at a concentration of 65% by weight.

[0079] Zirconia (zirconium dioxide) has one of the highest refractive indices in the family of metal oxides. The value of the refractive index varies slightly depending on the crystal structure (monoclinic, tetragonal, and cubic). Moreover, in well-crystallized solid ceramic materials, the refractive index is between 2.16 and 2.24. This property of the material makes it possible to consider its use to increase the refractive index of a medium, for example a solvent or a resin. If the nanoparticles are well dispersed in the medium and have a small enough primary particle size to avoid light scattering phenomena, the resulting composite nanomaterial may exhibit not only a high refractive index but also good transmittance.

[0080] The closer the refractive index of the nanoparticles is to the theoretical refractive index of the ceramic material (2.16-2.24), the more effective the nanoparticles will be in raising the refractive index of the composite, making it possible to obtain a higher refractive index for the same loading fraction. Generally, well-crystallized nanoparticles have a higher refractive index.

[0081] The refractive index of a nanocomposite material, which shows a good dispersion of the fillers and an approximately spherical morphology, can be calculated from the refractive index of each of the components. Conversely, the refractive index of the nanoparticles can be calculated from refractive index measurements made on nanocomposites of various concentrations, using a model representative of the system. Different equations derived from different mathematical models may be used for this calculation. Commonly used models for these systems include the Lorenz-Lorentz, Maxwell-Garnett, and Bruggman models, as well as linear approximations (J. Humlicek, "Data Analysis for Nanomaterials: Effective Medium Approximation, Its Limits and Implementations", Ellipsometry at the Nanoscale, 2013, pp. 145-178).

[0082] The lowest approximation model for the refractive index of nanoparticles is a linear approximation model, which is given by: RI nc = f m *RIm +f NP *RI NP

[0083] In this formula, RI nc is the refractive index of the nanocomposite, f m is the volume fraction of the medium, RI m is the refractive index of the medium, f NP is the volume fraction of nanoparticles, RI NP is the refractive index of the nanoparticles.

[0084] Advantageously, the zirconia nanoparticles according to the invention have a refractive index between 2.0 and 2.2, more advantageously between 2.10 and 2.15. The refractive index of the nanoparticles does not correspond to the refractive index measured in water on a dispersion of the nanoparticles. This is determined from measurements carried out on a dispersion of the nanoparticles, as shown in the section relating to the examples according to the invention.

[0085] The viscosity of the dispersion is typically measured in water at 20° C. using a rheometer, such as the Kinexus Pro+ model from Malvern Instruments. 2 Nanoparticles are dispersed in water at the desired concentration. To verify that this is a Newtonian fluid with constant viscosity as a function of shear rate, the viscosity is increased to 0.1 s -1 ~100s -1 Measure at various shear rates of 1s -1 The value measured at shear rate is reported as the viscosity of the dispersion. Viscosity at a fixed shear rate generally increases with increasing concentration.

[0086] In general, the nanoparticles according to the invention, at a concentration of 40% by weight in water, exhibit a viscosity of 1 to 10 mPa.s, advantageously of 2 to 8 mPa.s, even more advantageously of 2 to 6 mPa.s.

[0087] The nanoparticles obtained by the method according to the invention have an average primary particle size, determined by image analysis from a TEM (transmission electron microscopy) image of the nanoparticles placed on a support transparent to electron beams. The average primary particle size is understood to mean the average of the maximum length between two points on the surface of the nanoparticles for at least 300 nanoparticles. Thus, if the nanoparticles are perfectly spherical, the average primary particle size corresponds to the average diameter, whereas if the nanoparticles are not spherical, the average primary particle size corresponds to the average height of the smallest cylinder inscribed by the nanoparticles. The average primary particle size of the nanoparticles thus obtained by TEM is advantageously between 2 nm and 60 nm, more advantageously between 3 nm and 40 nm, even more advantageously between 4 nm and 20 nm, even more advantageously between 5 nm and 7 nm. A second indirect method for estimating the primary particle size is the Scherrer method. This method makes it possible to calculate the primary particle size by measuring the width at half maximum of the main diffraction peak (full width at half maximum, FWHM), after subtracting the component Ka2 from the diffraction spectrum and correcting the measured FWHM taking into account the peak broadening due to the device (instrumental peak broadening). The peaks selected for measurement are (-111) and (111) for the monoclinic phase, and (111) for the tetragonal / cubic phase. The crystallite size is then calculated by the Scherrer formula using a shape factor of 0.89.

[0088] The DLS (acronym stands for "Dynamic Light Scattering") technique makes it possible to measure by spectroscopic analysis the hydrodynamic diameter of particles present in a liquid medium, for example an aqueous medium such as water. In general, the hydrodynamic diameter differs from the primary particle size measured by TEM or DRX (Scherrer technique). This technique is also sensitive to the presence of particle aggregates. In appropriate cases, the values ​​measured by DLS are greater than the size of the particles in the absence of aggregates. Furthermore, the results of this analysis give the average hydrodynamic diameter in volume D V , the mean hydrodynamic diameter at intensity D I , the mean hydrodynamic diameter in numbers D N , and related D 50 and D. 90 D 50 The value is the value at which 50% of the particles measured are D 50This corresponds to the hydrodynamic diameter when the diameter is: D 90 The value is the value when 90% of the particles measured are D 90 These latter values ​​correspond to the hydrodynamic diameter when the volume (D V50 / D V90 ), number (D N50 / D N90 ), or strength (D I50 / D I90 ) can be calculated.

[0089] Number average hydrodynamic diameter (D N ) are preferably 3 nm to 50 nm, more preferably 4 nm to 30 nm. They are preferably D N50 They have a size preferably of D between 5 nm and 50 nm, more preferably between 6 nm and 40 nm. N90 Has a size.

[0090] Volume-average hydrodynamic diameter (D V ) is measured by DLS and is preferably 3 nm to 50 nm, more preferably 4 nm to 30 nm. The nanoparticles preferably have a D V50 They have a size preferably of D between 5 nm and 70 nm, more preferably between 6 nm and 40 nm. V90 Has a size.

[0091] The dispersion index (ID) corresponds to the ratio of the hydrodynamic diameter in volume of a particle, as measured by DLS, to the primary particle size of the particle, as measured by TEM.

[0092] Generally, the dispersions according to the present invention have a very low dispersion index in water, preferably from 1 to 7, more preferably from 1 to 4, even more preferably from 1 to 2, even more preferably from 1 to 1.5.

[0093] Depending on the experimental conditions, the nanoparticles obtained by the method according to the invention may be of crystalline tetragonal / cubic or monoclinic morphology or a mixture of both.

[0094] In a particular embodiment, the dispersion or paste may be dried, in which case a powder is obtained. The present invention therefore also relates to a powder obtained by drying the above dispersion or paste.

[0095] Obtaining a powder form offers certain advantages, since a powder can be stored and transported in a smaller volume than a dispersion. Moreover, the powder obtained by drying the dispersion according to the invention can be easily dispersed not only in water, but also in organic solvents, such as acetone, alcohols, such as ethanol, isopropanol, glycerol, or propylene glycol. It can also be dispersed in resins, especially for the production of composites. In general, when replacing an amino acid by another organic molecule according to the general knowledge of the person skilled in the art, good dispersions in organic solvents of various polarities are obtained.

[0096] Likewise, the powder can be dispersed at any pH, advantageously between 3 and 12. It can be made from nanoparticles in which the amino acids are replaced with organic molecules.

[0097] Indeed, in certain embodiments, the amino acid molecules are replaced after production of the zirconium dioxide nanoparticles.

[0098] As previously mentioned, a dispersion or powder of zirconium dioxide nanoparticles can be mixed with a resin to form a composite material.

[0099] ZrO 2 Use of Nanoparticles Zirconia is one of the most used materials in the dental field for the formulation of dental composites. They are photopolymerizable materials (near UV, wavelength 400 nm + / - 20 nm) consisting of an organic phase and an inorganic phase. The organic phase essentially consists of dimethacrylate monomers, a polymerization agent and a photoinitiator. The inorganic phase consists of inorganic fillers aimed at imparting or enhancing certain properties, for example improving the mechanical properties of the composite, reducing polymerization shrinkage, imparting radiopacity to the dental composite, etc. The dispersions of zirconia nanoparticles according to the invention are of particular interest in the dental field due to their high transmittance, which promotes the photopolymerization deep in the dental composite, and due to their improved esthetics.

[0100] Thus, composite materials particularly suitable for the dental field can be obtained from the above dispersions.

[0101] ZrO 2 Nanoparticles may also be used for their high refractive index (in the fields of surface coatings, composites, adhesives), their biocompatibility (in the fields of dental and orthopedic prostheses), their dielectric constant (in the fields of electronics), their aesthetics (in the fields of jewellery and watchmaking). They are also used to shape and densify dense ceramic materials or coatings, which may exhibit mechanical properties such as wear resistance, bending or compression resistance, and toughness, as well as improved aesthetics, such as visible transmittance (in the fields of technical ceramics, biomedical ceramics, and 3D printing materials). EXAMPLES

[0102] (Examples 1 to 23 (present invention)) Unless otherwise specified, percentages of dispersion components are expressed by weight.

[0103] As far as doping is concerned, it is expressed as a molar percentage relative to the molar amount of zirconium. This is commonly done with yttrium oxide (Y 2 O 3 ), cerium oxide (CeO 2 ), or gadolinium oxide (Gd2 O 3 ) content. Therefore, 3 mol% yttrium is 3 mol% Y 2 O 3 This corresponds to doping of 100 times the concentration of dopant.

[0104] Into the autoclave are introduced the zirconium IV compound, the amino acid, its precursor or a mixture of several amino acids, and optionally water and / or a doping agent, which is then sealed and brought to the desired temperature and pressure.

[0105] The process conditions are listed below in Table 1. The pH before hydrothermal treatment for Examples 1-23 is 1-5.

[0106] [Table 1A]

[0107] [Table 1B]

[0108] (Example CE1~CE6 (comparative example)) Comparative tests were carried out according to the methods given in Examples 1 to 23 in the presence of the following compounds or mixtures (Table 2). - Butanoic acid + butylamine (example CE1). - Amino acids with two amine functions and one acid function (example CE2). - Butanoic acid (e.g. CE3). - Butylamine (example CE4). - Aminocaproic acid + NH 4 OH is added gradually to bring the pH to 12 before hydrothermal treatment (example CE5). - Add NaOH, precipitate and purify with water (until a conductivity of less than 250 μS / cm), add acetic acid, final pH less than 7 (Example CE6, carried out according to EP 2,371,768).

[0109] [Table 2]

[0110] Once the hydrothermal treatment is complete, the temperature and pressure are reduced so that the autoclave can be safely opened. The reaction medium is then optionally washed and / or diluted, or concentrated, to obtain a dispersion in water, a fluid, having a concentration of zirconium dioxide nanoparticles of 40% or 65% by weight.

[0111] Each of the resulting dispersions is then analyzed. The state of aggregation of the dispersions is measured by DLS. The stability of the dispersions of various concentrations is visually measured by the appearance of precipitates after waiting for 10 days undisturbed at 20°C. The dispersion index (ID) is determined by the ratio of the hydrodynamic diameter in volume of the particles measured by DLS to the primary particle size of the particles measured by TEM only in those cases that show a single crystalline phase with a spherical morphology, which corresponds to the monoclinic phase (M) if the particle size is less than 10 nm, or corresponds to the tetragonal / cubic phase (Q). If the dispersion has different crystalline phases, including the monoclinic phase (M) that shows anisotropic particles with a primary particle size of more than 10 nm, the ID is not calculated. The primary particle size measured by TEM for anisotropically shaped particles less than 10 nm in monoclinic phase corresponds to the length of the long axis of the particle. The viscosity is measured by a Malvern Instrument, model Kinexus Pro +, using a cone / plate configuration with a diameter of 40 mm and a tilt of 4° at 20°C. The refractive index of the dispersion is measured at 20° C. and 589 nm with an Anton Paar instrument, model Abbemat 200.

[0112] Therefore, a Bruker D8 Advance diffractometer with Cu K-alpha radiation at 2θ angles between 10 and 75° was used to identify characteristic peaks and assign them to either the tetragonal / cubic (Q) or monoclinic (M) phases by comparison with the X-ray diffraction database of the International Center for Diffraction Data. The relative intensity of peak 111 for phase Q and the sum of the relative intensities of peaks -111 and 111 for phase M were used to determine the predominant phase (Table 3).

[0113] [Table 3A]

[0114] [Table 3B]

[0115] According to the present invention, ZrO 2 Stable dispersions of nanoparticles were obtained in all Examples 1-23.

[0116] [Table 4]

[0117] In the absence of an amino acid, or when the amino acid does not correspond to those used in the present invention, or when a mixture of an acid and an amine is used, or in the presence of an amino acid used in the present invention, if the pH is above 7, the resulting dispersion is unstable, especially due to the presence of particle agglomerates.

[0118] Thus, among the counterexamples, only CE6 makes it possible to obtain a stable dispersion when the concentration is below 40% by weight. On the other hand, above 40% by weight of nanoparticles, the dispersion becomes very viscous and starts to solidify and dry out. Thus, in the case of counterexample CE6, it is not possible to obtain a dispersion at a nanoparticle concentration above 40% by weight.

[0119] The transmittance of dispersions of nanoparticles according to Examples 6, 12-16, 19 and 22, and according to counter example CE6, at a concentration of 40% by weight was measured. The transmittance in the range of 400-800 nm was measured with a Jasco Model V-670 instrument and is listed in Table 5.

[0120] [Table 5]

[0121] Thus, at the maximum concentration that makes it possible to obtain a stable dispersion according to counterexample CE6, ie a concentration of 40% by weight of nanoparticles, the dispersion according to the invention shows a better total transmittance at 400 nm and 800 nm.

[0122] On the other hand, even at 65% by weight, excellent transmittance can be obtained. The transmittance of the dispersions containing nanoparticles of Examples 14, 15, and 16 was measured at various concentrations according to the method described above. The results are shown in Table 6 below.

[0123] [Table 6]

[0124] Figure 2 visually illustrates the transmittance of a dispersion according to the invention. Three samples 1, 2, and 3 of a dispersion according to the invention are placed in front of image 4. Sample 1 is a dispersion containing 50% by weight of nanoparticles of Example 16. Sample 2 is a dispersion containing 65% by weight of nanoparticles of Example 16. Sample 3 is a dispersion containing 40% by weight of nanoparticles of Example 9.

[0125] The dispersion of sample 3 has a lower transmittance than the two dispersions of samples 1 and 2. Even though sample 3 is slightly colored, the transmittance of sample 3 is still very satisfactory since image 4 placed behind the sample can be easily discerned.

[0126] As far as the two samples 1 and 2 are concerned, they have a very high transmittance which makes it possible to see the image 4 very clearly without any colour correction. The magnification effect which can be seen in figure 2 is due to the container and not the dispersion.

[0127] (Examples 24 and 25) Using the procedure of precipitation and functionalization with molecules having phosphoric acid functionality, the particles of Examples 12 and 16 were redispersed in acetone. A stable and transparent dispersion of the particles in acetone was obtained.

[0128] (Examples 26 and 27) The particles of Examples 12 and 16 dispersed in acetone after replacement of the amino acids with molecules having phosphate functional groups were redispersed in a monomer such as 1,10-decanediol dimethacrylate (D3MA) using a procedure of initial solvent uptake and evaporation, resulting in a stable and transparent dispersion of the particles in D3MA.

[0129] (Example 28) The particles from Example 16 were redispersed in propylene glycol without amino acid substitution using the procedure of precipitation and redispersion in the final solvent. A stable and transparent dispersion of the particles in propylene glycol was obtained.

[0130] The total transmittance was measured at various concentrations for the dispersions of Examples 24-28. The total transmittance values ​​are reported as a percentage of the transmittance measured for the corresponding pure solvent-filled tank. These are listed in Table 7.

[0131] [Table 7]

[0132] It is therefore possible for the zirconium nanoparticles obtained according to the invention to be redispersed in solvents other than water and to maintain not only excellent transmittance at high concentrations but also low viscosity and high stability over time.

[0133] Example 29 (present invention) Example 29 can be compared to Example 9, with only two synthesis parameters being modified: the amounts of zirconium precursor, yttrium, aminobutyric acid and water are the same, and 6-aminocaproic acid is added. The procedure for dissolving the solids is different: the zirconium precursor is dissolved in water together with 4-aminobutyric acid; the yttrium precursor is dissolved in water in the presence of 6-aminocaproic acid; after complete dissolution, the two solutions are mixed.

[0134] 36 mmol of zirconium oxychloride, 119 mmol of 4-aminobutyric acid (ACA4), and 36 ml of water are introduced into a beaker. In a second beaker, yttrium chloride (6 mol% Y 2 O 3 (doped), 23.8 mmol of 6-aminocaproic acid (ACA6), and 36 mL of water are introduced. After complete dissolution, the two solutions are mixed and introduced into a 100 mL autoclave. The autoclave is then sealed and heated at 200 °C for 3 h, with a pressure of 12-15 bar.

[0135] In Example 29, ZrO 2 A stable dispersion of nanoparticles was obtained.

[0136] Unlike in Example 9, the diffractogram obtained by X-ray diffraction analysis shows the unique presence of tetragonal / cubic phases. Only the image analysis of the TEM images of the nanoparticles obtained in Example 29 shows the presence of spherical particles with an average primary particle size of 20 nm.

[0137] (Example 30) The nanoparticles obtained according to examples 12 and 15 were washed with water and concentrated to various concentrations. The level of amino acids present on the surface of the nanoparticles was measured by TGA (thermogravimetric analysis). The refractive index of the resulting dispersions was measured at a wavelength of 589 nm and a temperature of 20° C. using a refractometer (Anton Paar, Abbemat 200). The density of the nanoparticles bearing (or functionalized) amino acids on their surface was calculated by linear approximation. The refractive index of the functionalized nanoparticles was calculated by linear regression from the refractive index values ​​of the dispersions measured as a function of the volume fraction of functionalized nanoparticles by a linear approximation model. The refractive index of the non-functionalized (or bare) nanoparticles was calculated taking into account the level of functionalizing agent present on the surface. The results of these measurements and calculations are shown in Table 8.

[0138] [Table 8]

[0139] For the nanoparticles of Example 12, after washing, the level of amino acids present on the surface as measured by TGA was 4.3 wt % based on the total weight of the nanoparticles after drying, and the density of the non-functionalized nanoparticles was 6.14 g / cm 3 The density of the functionalized nanoparticles is 5.16 g / cm 3 The density of the medium is 0.998 and its refractive index is 1.3330. The density of the functionalizing agent (ACA6) is 1.13 g / cm 3 and its refractive index is 1.4870. The refractive index of the resulting non-functionalized nanoparticles is 2.1434, with a correlation coefficient of measurement of 0.9990.

[0140] After washing the nanoparticles of Example 15, the level of amino acids present on the surface as measured by TGA was 4.3 wt % based on the total weight of the nanoparticles after drying, and the density of the non-functionalized nanoparticles was 6.00 g / cm 3 The density of the functionalized nanoparticles is 4.72 g / cm 3 The density of the medium is 0.998 and its refractive index is 1.3330. The density of the functionalizing agent (ACA6) is 1.13 g / cm 3and its refractive index is 1.4870. The refractive index of the resulting non-functionalized nanoparticles is 2.1011, with a correlation coefficient of measurement of 0.9999.

[0141] It should be noted that the linear fit model underestimates the refractive index of the nanoparticles, therefore non-functionalized nanoparticles have refractive indices equal to or greater than the calculated value.

Claims

1. Zirconium dioxide (ZrO) can be obtained by hydrothermal treatment of a zirconium IV compound in the presence of water, at a pH of less than 7, and in the presence of at least one amino acid containing at least 4 carbon atoms, the ratio of acid functional groups to amine functional groups being equal to or greater than 1. 2 A method for preparing nanoparticles of

2. 2. The method according to claim 1, characterized in that the hydrothermal treatment is carried out at a temperature of at least 100° C. and at a pressure of at most 2 MPa.

3. 3. The method according to claim 1 or 2, characterized in that the zirconium IV compound is selected from the group consisting of zirconium halides.

4. 4. The method according to claim 1, wherein the amino acid is selected from the group consisting of aminobutanoic acid, aminopentanoic acid and aminohexanoic acid.

5. 5. The method according to claim 1, wherein the amino acids are produced in situ by hydrolysis from amino acid precursors.

6. 6. The process according to claim 1, wherein the water of the hydrothermal treatment is obtained exclusively from hydrated forms of zirconium IV compounds.

7. 7. The method according to claim 1, wherein the hydrothermal treatment is carried out at a pressure between 0.1 MPa and 0.6 MPa.

8. 8. The process according to claim 1, wherein the amino acid is present in a molar ratio of 1 to 50 relative to the zirconium IV compound.

9. 9. The method according to claim 1, wherein the hydrothermal treatment is carried out in the presence of one or more dopant sources.

Citation Information

Patent Citations

  • EP2,371,768B1

  • FR2,899,906

  • Zirconium oxide dispersion, method for producing the same and resin composition containing the same

    JP2010132494A

  • Metal oxide nanostructure and method for manufacturing the same

    JP2014034495A

  • Mesoporous compound comprising a mineral phase of aluminum and cerium, titanium or zirconium oxide particles and, optionally, an element in solid solution in said particles, the preparation method thereof and uses of same

    US20050123465A1